Optimal Incision Site Design for Lymphaticovenular Anastomosis in Extremity Lymphedema
NCT ID: NCT06188858
Last Updated: 2024-01-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
267 participants
OBSERVATIONAL
2020-01-01
2023-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Identification of the Optimal Functional Lymphatic Vessel for Lymphaticovenous Anastomosis
NCT06191081
Lymphedema Duration on Lymphatic Vessel Quality and Outcomes After LVA
NCT06323200
Supermicrosurgical LVA for Lymphedema Treatment
NCT04285762
Efficacy of Lymphovenous Bypass in the Treatment of Extremity Lymphedema
NCT03683095
Effect of Lymphovenous Anastomosis on Lower Limb Lymphedema: Pragmatic Randomized Controlled Trial
NCT07073586
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
question 1：Optimal Incision Site Design for Lymphaticovenular Anastomosis in Extremity lymphedema
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Taizhou Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Haihua Yang
Chief Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
yomao zheng
Role: STUDY_DIRECTOR
employee
chong liu
Role: PRINCIPAL_INVESTIGATOR
employee
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chong Liu
Zhejiang, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Taizhou Hospital OISD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.